Transdiagnostic dimensions of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP).

Psychosis biotypes bipolar disorder with psychosis general symptom dimensions schizoaffective disorder schizophrenia specific symptom dimensions transdiagnostic phenotypes

Journal

World psychiatry : official journal of the World Psychiatric Association (WPA)
ISSN: 1723-8617
Titre abrégé: World Psychiatry
Pays: Italy
ID NLM: 101189643

Informations de publication

Date de publication:
Feb 2019
Historique:
entrez: 3 1 2019
pubmed: 3 1 2019
medline: 3 1 2019
Statut: ppublish

Résumé

The validity of the classification of non-affective and affective psychoses as distinct entities has been disputed, but, despite calls for alternative approaches to defining psychosis syndromes, there is a dearth of empirical efforts to identify transdiagnostic phenotypes of psychosis. We aimed to investigate the validity and utility of general and specific symptom dimensions of psychosis cutting across schizophrenia, schizoaffective disorder and bipolar I disorder with psychosis. Multidimensional item-response modeling was conducted on symptom ratings of the Positive and Negative Syndrome Scale, Young Mania Rating Scale, and Montgomery-Åsberg Depression Rating Scale in the multicentre Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) consortium, which included 933 patients with a diagnosis of schizophrenia (N=397), schizoaffective disorder (N=224), or bipolar I disorder with psychosis (N=312). A bifactor model with one general symptom dimension, two distinct dimensions of non-affective and affective psychosis, and five specific symptom dimensions of positive, negative, disorganized, manic and depressive symptoms provided the best model fit. There was further evidence on the utility of symptom dimensions for predicting B-SNIP psychosis biotypes with greater accuracy than categorical DSM diagnoses. General, positive, negative and disorganized symptom dimension scores were higher in African American vs. Caucasian patients. Symptom dimensions accurately classified patients into categorical DSM diagnoses. This study provides evidence on the validity and utility of transdiagnostic symptom dimensions of psychosis that transcend traditional diagnostic boundaries of psychotic disorders. Findings further show promising avenues for research at the interface of dimensional psychopathological phenotypes and basic neurobiological dimensions of psychopathology.

Identifiants

pubmed: 30600629
doi: 10.1002/wps.20607
pmc: PMC6313235
doi:

Types de publication

Journal Article

Langues

eng

Pagination

67-76

Subventions

Organisme : US National Institute of Mental Health
ID : MH-077851
Organisme : Netherlands Organization for Scientific Research
ID : 451-13-022
Organisme : NIMH NIH HHS
ID : R01 MH103366
Pays : United States
Organisme : US National Institute of Mental Health
ID : MH-078113
Organisme : US National Institute of Mental Health
ID : MH-077945
Organisme : NIMH NIH HHS
ID : K23 MH102656
Pays : United States
Organisme : US National Institute of Mental Health
ID : MH-077862
Organisme : US National Institute of Mental Health
ID : MH-077852

Informations de copyright

© 2019 World Psychiatric Association.

Références

Behav Res Ther. 2002 May;40(5):485-99
pubmed: 12038642
Am J Psychiatry. 2005 Jan;162(1):12-24
pubmed: 15625195
Psychopathology. 2005 Jul-Aug;38(4):211-4
pubmed: 16145277
Schizophr Res. 2007 Sep;95(1-3):30-8
pubmed: 17669627
J Clin Psychiatry. 2007 Nov;68(11):1673-81
pubmed: 18052560
Soc Psychiatry Psychiatr Epidemiol. 2008 Sep;43(9):743-51
pubmed: 18491023
Int J Approx Reason. 2008 Jan;47(1):17-36
pubmed: 19079753
Lancet. 2009 Jan 17;373(9659):234-9
pubmed: 19150704
J Clin Psychiatry. 2009 Oct;70(10):1432-8
pubmed: 19538905
Lancet. 2009 Aug 22;374(9690):635-45
pubmed: 19700006
Psychol Med. 2009 Dec;39(12):2025-42
pubmed: 19796428
Schizophr Res. 2010 Dec;124(1-3):43-8
pubmed: 20855184
Schizophr Bull. 2010 Nov;36(6):1061-2
pubmed: 20929969
Schizophr Bull. 2013 Jul;39(4):884-95
pubmed: 22258881
Br J Psychiatry. 1990 Dec;157:853-9
pubmed: 2289094
Clin Schizophr Relat Psychoses. 2012 Oct;6(3):145-51
pubmed: 23006239
Schizophr Bull. 2014 Jan;40(1):111-9
pubmed: 23661632
BMC Med. 2013 May 14;11:126
pubmed: 23672542
Am J Psychiatry. 2013 Nov;170(11):1263-74
pubmed: 23846857
Schizophr Res. 2013 Oct;150(1):38-9
pubmed: 23880134
World Psychiatry. 2014 Feb;13(1):28-35
pubmed: 24497240
Schizophr Bull. 2014 Mar;40 Suppl 2:S131-7
pubmed: 24562492
Schizophr Bull. 2014 May;40(3):504-15
pubmed: 24567502
World Psychiatry. 2015 Feb;14(1):27-9
pubmed: 25655146
Am J Psychiatry. 2016 Apr 1;173(4):373-84
pubmed: 26651391
World Psychiatry. 2016 Feb;15(1):1-2
pubmed: 26833594
World Psychiatry. 2016 Feb;15(1):26-31
pubmed: 26833601
Br J Psychiatry. 2016 Aug;209(2):107-13
pubmed: 26989099
World Psychiatry. 2016 Jun;15(2):118-24
pubmed: 27265696
World Psychiatry. 2016 Oct;15(3):193-194
pubmed: 27717257
World Psychiatry. 2017 Feb;16(1):5-13
pubmed: 28127906
World Psychiatry. 2017 Jun;16(2):142-144
pubmed: 28498590
Am J Psychiatry. 2017 Jul 1;174(7):613-615
pubmed: 28669209
World Psychiatry. 2017 Oct;16(3):227-235
pubmed: 28941101
World Psychiatry. 2018 Feb;17(1):24-25
pubmed: 29352543
World Psychiatry. 2018 Jun;17(2):121-122
pubmed: 29856539
World Psychiatry. 2018 Jun;17(2):133-142
pubmed: 29856558
World Psychiatry. 2018 Jun;17(2):187-195
pubmed: 29856559
World Psychiatry. 2018 Oct;17(3):282-293
pubmed: 30229571
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692

Auteurs

Ulrich Reininghaus (U)

Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
Centre for Epidemiology and Public Health, Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Jan R Böhnke (JR)

Dundee Centre for Health and Related Research, School of Nursing and Health Sciences, University of Dundee, Dundee, UK.
Department of Health Sciences, University of York, York, UK.

UnYoung Chavez-Baldini (U)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.

Robert Gibbons (R)

Department of Medicine and Public Health Sciences, University of Chicago, Chicago, IL, USA.

Elena Ivleva (E)

Department of Psychiatry, UT Southwestern University, Dallas, TX, USA.

Brett A Clementz (BA)

Departments of Psychology and Neuroscience, Bio-Imaging Research Center, University of Georgia, Athens, GA, USA.

Godfrey D Pearlson (GD)

Department of Psychiatry, Yale University, New Haven, CT, USA.

Matcheri S Keshavan (MS)

Beth Israel Hospital, Harvard University, Boston, MA, USA.

John A Sweeney (JA)

Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, OH, USA.

Carol A Tamminga (CA)

Department of Psychiatry, UT Southwestern University, Dallas, TX, USA.

Classifications MeSH